Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05511519
What this trial is testing

Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Aclaris Therapeutics, Inc. 47
Testing effectiveness (Phase 2)Looking for participantsNCT07489885
What this trial is testing

Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
InventisBio Co., Ltd 75
Testing effectiveness (Phase 2)Study completedNCT01154101
What this trial is testing

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Sirtris, a GSK Company 40
Post-approval studies (Phase 4)Study completedNCT02690701
What this trial is testing

Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 91
Not applicableUnknownNCT05144165
What this trial is testing

Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines

Who this might be right for
PsoriasisPsoriasis PalmarisPsoriasis Inverse+8 more
Centre of Evidence of the French Society of Dermatology 30
Not applicableStudy completedNCT00930592
What this trial is testing

Peds Metabolic Syndrome in Psoriasis

Who this might be right for
PsoriasisMetabolic Syndrome
Tufts Medical Center 42
Not applicableStudy completedNCT01076192
What this trial is testing

Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 547
Large-scale testing (Phase 3)Study completedNCT05975268
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Shanghai Junshi Bioscience Co., Ltd. 747
Large-scale testing (Phase 3)Study completedNCT02672852
What this trial is testing

BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment

Who this might be right for
Psoriasis
AbbVie 507
Large-scale testing (Phase 3)Study completedNCT04595409
What this trial is testing

Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bioeq GmbH 392
Large-scale testing (Phase 3)Study completedNCT02762955
What this trial is testing

Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Biocad 344
Large-scale testing (Phase 3)Active Not RecruitingNCT06095115
What this trial is testing

JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 684
Post-approval studies (Phase 4)Looking for participantsNCT07503652
What this trial is testing

Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
First Hospital of China Medical University 10
Post-approval studies (Phase 4)Study completedNCT00932113
What this trial is testing

Mechanism of Action Study for Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00504270
What this trial is testing

R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Who this might be right for
Psoriasis
Hoffmann-La Roche 66
Not applicableStudy completedNCT05758402
What this trial is testing

A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study)

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 368
Large-scale testing (Phase 3)Study completedNCT00267969
What this trial is testing

Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor Research & Development, Inc. 766
Post-approval studies (Phase 4)Study completedNCT03055494
What this trial is testing

Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 102
Testing effectiveness (Phase 2)Study completedNCT03442088
What this trial is testing

Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast

Who this might be right for
Plaque Psoriasis
University Hospitals Cleveland Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT03895372
What this trial is testing

Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 179
Next Page